| scholarly article | Q13442814 |
| P2093 | author name string | André Nussenzweig | |
| Karl Sperling | |||
| Martin Digweed | |||
| Susanne Rothe | |||
| Bastian Salewsky | |||
| Harald Krenzlin | |||
| Petra Wessendorf | |||
| Kerstin Borgmann | |||
| Janina Radszewski | |||
| Gabriele Hildebrand | |||
| Ann Christin Parplys | |||
| Moritz Kieslich | |||
| P2860 | cites work | Nijmegen breakage syndrome (NBS) | Q21202860 |
| Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis | Q24291532 | ||
| NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain | Q24316234 | ||
| Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome | Q24316811 | ||
| The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response | Q24316950 | ||
| Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study | Q24643018 | ||
| Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions | Q26261171 | ||
| Nbs1 Flexibly Tethers Ctp1 and Mre11-Rad50 to Coordinate DNA Double-Strand Break Processing and Repair | Q27657670 | ||
| Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis | Q28594255 | ||
| ESEfinder: A web resource to identify exonic splicing enhancers | Q29616126 | ||
| An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers | Q33249150 | ||
| Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides. | Q33868227 | ||
| Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues | Q34016276 | ||
| Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models | Q34427548 | ||
| Active role for nibrin in the kinetics of atm activation | Q34519762 | ||
| Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase | Q34563205 | ||
| Efficient in vivo manipulation of alternative pre-mRNA splicing events using antisense morpholinos in mice | Q34675818 | ||
| Factor XI antisense oligonucleotide for prevention of venous thrombosis | Q35200286 | ||
| Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin | Q36562899 | ||
| Heterozygous mutations in PALB2 cause DNA replication and damage response defects | Q37305285 | ||
| Antisense-mediated exon skipping: taking advantage of a trick from Mother Nature to treat rare genetic diseases | Q38184276 | ||
| The essential function of the MRN complex in the resolution of endogenous replication intermediates. | Q39037557 | ||
| Nijmegen breakage syndrome: the clearance pathway for mutant nibrin protein is allele specific | Q39185633 | ||
| DNA damage by X-rays and their impact on replication processes. | Q39653518 | ||
| Replication fork movement sets chromatin loop size and origin choice in mammalian cells | Q39948771 | ||
| Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress. | Q40035632 | ||
| An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele | Q40816086 | ||
| SV40 T antigen interacts with Nbs1 to disrupt DNA replication control. | Q40903834 | ||
| Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence | Q41168085 | ||
| Mild Nijmegen breakage syndrome phenotype due to alternative splicing | Q41919921 | ||
| A new chromosome instability disorder. | Q41933219 | ||
| Deficiency of the DNA repair protein nibrin increases the basal but not the radiation induced mutation frequency in vivo. | Q42474228 | ||
| Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome | Q44452386 | ||
| Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study | Q45033314 | ||
| Eteplirsen for the treatment of Duchenne muscular dystrophy | Q45855674 | ||
| Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. | Q52542455 | ||
| An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability. | Q52943096 | ||
| The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy | Q72427693 | ||
| Chromosome instability and nibrin protein variants in NBS heterozygotes | Q73302618 | ||
| Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS) | Q79662700 | ||
| Clinical variability and expression of the NBN c.657del5 allele in Nijmegen Breakage Syndrome | Q84300269 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | Nijmegen breakage syndrome | Q1250362 |
| alternative mRNA splicing, via spliceosome | Q21114084 | ||
| P304 | page(s) | 117-124 | |
| P577 | publication date | 2015-08-12 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application | |
| P478 | volume | 24 |
Search more.